MedTrace Logo

PACED-digitized Support During Adjuvant Endocrine Therapy

NCT05084625 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-04-17

No results posted yet for this study

Summary

The research team want to investigate whether digital support, an app under preventive hormonal breast cancer treatment can lead to less late side effects, better quality of life and increased adherence to treatment.

Conditions

  • Breast Cancer
  • Treatment Adherence
  • Quality of Life
  • Treatment Side Effects

Interventions

OTHER

Digitized support

Access to information about the disease, treatment, side effects and self-care

Sponsors & Collaborators

  • ScientificMed Tech AB

    collaborator UNKNOWN

  • AstraZeneca

    collaborator INDUSTRY

  • Novartis Sverige AB

    collaborator UNKNOWN

  • Bröstcancerförbundet

    collaborator UNKNOWN

  • Stockholm South General Hospital

    collaborator OTHER

  • Capio St Gorans hospital

    collaborator UNKNOWN

  • Karolinska University Hospital

    collaborator OTHER

  • Region Stockholm

    lead OTHER_GOV

Principal Investigators

  • Jenny Bergqvist · St Gorans Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-25
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05084625 on ClinicalTrials.gov